Biology of prostate-specific antigen

Area of Science:

• Biochemistry
• Oncology
• Genetics

Background:

• The human kallikrein (HK) family, located on chromosome 19, includes key enzymes like prostate-specific antigen (PSA).
• While PSA is used for prostate cancer detection, its precise functions and regulatory mechanisms remain incompletely understood.
• PSA forms complexes with alpha1-antichymotrypsin and alpha2-macroglobulin, which may be relevant for disease detection and progression.

Purpose of the Study:

• To elucidate the regulatory mechanisms of PSA and its role in prostate cancer.
• To explore the potential involvement of other HK family members (hK2, hK4, hK15) in PSA activation and prostate cancer progression.
• To investigate how understanding PSA function and expression can inform prostate cancer screening and treatment.

Main Methods:

• Analysis of PSA complex formation with protease inhibitors (alpha1-antichymotrypsin, alpha2-macroglobulin).
• Investigation of the role of hK2, hK4, and hK15 in the conversion of pro-PSA to active PSA.
• Review of emerging data on HK gene product signaling in early prostate cancer detection.

Main Results:

• PSA forms complexes with alpha1-antichymotrypsin and alpha2-macroglobulin, offering potential disease markers.
• Emerging data suggest hK2, hK4, and hK15 are crucial for activating PSA from its pro-form.
• Sensitive signaling of prostate cancer has been observed up to 20 years before clinical diagnosis.

Conclusions:

• Understanding PSA regulation and the function of related HK enzymes is vital for advancing prostate cancer detection and treatment.
• PSA and other HK family members may play critical roles in controlling tumor invasion and progression.
• Early signaling detection could revolutionize prostate cancer screening protocols and therapeutic options.